Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morganroth

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
Circulation|October 1, 1989
Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapyJ H Levine, J Morganroth, A H Kadish
Clinical Therapeutics|January 1, 1986
Oral antiarrhythmic agents for ventricular arrhythmiasM D Meissner, P F Nestico, J Morganroth
The New England Journal of Medicine|June 6, 1974
Treatment of hyperlipidemiaR I Levy, J Morganroth, B M Rifkind
Annals of Internal Medicine|September 1, 1985
Tocainide: a new oral antiarrhythmic agentS P Kutalek, J Morganroth, L N Horowitz
Annals of Internal Medicine|June 1, 1980
Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac deathW P Follansbee, E L Michelson, J Morganroth
The American Journal of Cardiology|February 1, 1980
Superior QRS axis of ventricular premature complexes: an additional criterion to enhance the sensitivity of exercise stress testingT J Mardelli, J Morganroth, L S Dreifus
American Heart Journal|October 1, 1985
A review of the uses and limitations of tocainide--a class IB antiarrhythmic agentJ Morganroth, P F Nestico, L N Horowitz
Circulation|June 1, 1983
Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experienceE Lichstein, J Morganroth, R Harrist, et al.
The American Journal of Cardiology|June 1, 1977
Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlatesM E Josephson, J A Kastor, J Morganroth
The American Journal of Digestive Diseases|March 1, 1972
Cellular and humoral sensitivity to gluten fractions in patients with treated nontropical sprueJ Morganroth, D W Watson, A B French
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
Circulation|October 1, 1989
Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapyJ H Levine, J Morganroth, A H Kadish
Clinical Therapeutics|January 1, 1986
Oral antiarrhythmic agents for ventricular arrhythmiasM D Meissner, P F Nestico, J Morganroth
The New England Journal of Medicine|June 6, 1974
Treatment of hyperlipidemiaR I Levy, J Morganroth, B M Rifkind
Annals of Internal Medicine|September 1, 1985
Tocainide: a new oral antiarrhythmic agentS P Kutalek, J Morganroth, L N Horowitz
Annals of Internal Medicine|June 1, 1980
Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac deathW P Follansbee, E L Michelson, J Morganroth
The American Journal of Cardiology|February 1, 1980
Superior QRS axis of ventricular premature complexes: an additional criterion to enhance the sensitivity of exercise stress testingT J Mardelli, J Morganroth, L S Dreifus
American Heart Journal|October 1, 1985
A review of the uses and limitations of tocainide--a class IB antiarrhythmic agentJ Morganroth, P F Nestico, L N Horowitz
Circulation|June 1, 1983
Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experienceE Lichstein, J Morganroth, R Harrist, et al.
The American Journal of Cardiology|June 1, 1977
Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlatesM E Josephson, J A Kastor, J Morganroth
The American Journal of Digestive Diseases|March 1, 1972
Cellular and humoral sensitivity to gluten fractions in patients with treated nontropical sprueJ Morganroth, D W Watson, A B French
Pageof 22